ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,29
-0,78%
Dow Jones
40 211,72
0,53%
DAX
18 500,51
-0,54%
Brent Oil
83,235
-1,31%
Bitcoin
63 700,00
-1,78%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
08/12/202113h00Business WirePureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
07/12/202113h00Business WirePureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
01/12/202113h10Business WirePureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition OfficerNASDAQ:PRTCPureTech Health PLC
18/11/202113h10Business WirePureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from RoNASDAQ:PRTCPureTech Health PLC
16/11/202113h00Business WirePureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing UpdatesNASDAQ:PRTCPureTech Health PLC
15/11/202113h00Business WirePureTech Announces Participation in Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
12/11/202113h00Business WirePureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual MeetingNASDAQ:PRTCPureTech Health PLC
11/11/202113h00Business WirePureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic CancerNASDAQ:PRTCPureTech Health PLC
10/11/202112h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
09/11/202113h37Business WirePureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater ChinaNASDAQ:PRTCPureTech Health PLC
09/11/202108h00Business WirePureTech Announces Participation at the Jefferies London Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
01/11/202111h20Business WirePureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut DamageNASDAQ:PRTCPureTech Health PLC
14/10/202113h01Business WirePureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate SecretaryNASDAQ:PRTCPureTech Health PLC
05/10/202114h01Business WirePureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDANASDAQ:PRTCPureTech Health PLC
05/10/202114h00Business WirePureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-BeingNASDAQ:PRTCPureTech Health PLC
29/09/202114h02Business WirePureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in JapanNASDAQ:PRTCPureTech Health PLC
20/09/202117h04Business WirePureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin ResistanceNASDAQ:PRTCPureTech Health PLC
14/09/202113h00Business WirePureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech SummitNASDAQ:PRTCPureTech Health PLC
10/09/202108h00Business WirePureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
24/08/202108h00Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
23/08/202113h00Business WirePureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021NASDAQ:PRTCPureTech Health PLC
17/08/202114h05Business WirePureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive ImpairmentsNASDAQ:PRTCPureTech Health PLC
13/08/202113h00Business WirePureTech Announces the Appointment Julie Krop, M.D., as Chief Medical OfficerNASDAQ:PRTCPureTech Health PLC
11/08/202113h00Business WirePureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain SyndromeNASDAQ:PRTCPureTech Health PLC
03/08/202108h00Business WirePureTech: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
22/07/202114h09Business WirePureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHDNASDAQ:PRTCPureTech Health PLC
21/07/202113h03Business WirePureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D FinancingNASDAQ:PRTCPureTech Health PLC
19/07/202113h02Business WirePureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special ...NASDAQ:PRTCPureTech Health PLC
09/07/202113h00Business WirePureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Tran...NASDAQ:PRTCPureTech Health PLC
08/07/202115h05Business WirePureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology...NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

BIT
FLOT
Exchange Traded
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés